chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had no symptoms after receiving the first dose, but after receiving the second dose I developed a high fever of 103 degrees as well as body aches, hypersensitivity, dizziness, migraines, and diarrhea. I eventually began taking ibuprofen to manage the symptoms, starting on night one. I then usually took ibuprofen twice a day after that. My symptoms were completely treated by ibuprofen and nearly all of them disappeared when I took it, besides the diarrhea. Oddly I also developed cold sweats when taking ibuprofen, which would dissipate after the ibuprofen stopped working. The symptoms kept coming back, as far as a week later, however, I didn?t have to take as much ibuprofen as before because they were becoming intermittent. Today, I almost got through the whole day without a return of any of my symptoms, until about 11:00 PM, after which all symptoms came back, the difference being that my fever is now low grade. This has been the case for two days now, no symptoms until night, when they all return promptly.
11/5/07 PT. RECEIVED YELLO FEVER VACCINATION; 11/7-8 PT STATED "ITCHINESS" BEGAN; 11/11 PT REPORTS 6/10 "ACHINESS" AT INJECTION SITE WITH ERRYTHEMA AND PRURITUS. 11/11 PT NOTICED ARM WAS "FEVERISH" AND USED ICE PACKS TO SITE. LEFT OUTDER ARM CONTINUES TO BE WARM TO TOUCH WITH ERRYTHMA APPROX 2.5" X 2.5" AROUND INJECTION SITE. PT. DENIES FEVER, DIAPHORESIS, CHILLS, CHANGE IN MENTAL STATUS.
On 3 Sep 21 my blood pressure monitor showed an Irregular Heartbeat and pulse of 41 BPM.  I was diagnosed by the ER with Bradycaria and an irregular heartbeat.  Follow-up added PVC, Tacheycardia, and AFIB through Holter Monitor and Echocardiogram,  My Echocardiogram was normal.  I was put on a beta blocker which reduced my pulse to 31 BPM.  I was given a pacemaker.
Information has been received from a nurse practitioner concerning an 18 year old female with minocycline hypersensitivity who on 04-SEP-2007 at 2:12 pm was vaccinated with 0.5 ml second does of GARDASIL. Concomitant therapy included ADDERALL TABLETS, ORTHO TRI-CYCLEN LO, tetracycline, vitamins (unspecified) and hydrochloride. On 04-SEP-2007 immediately after vaccination she started to feel lightheaded. She reported not having eaten all day. She felt better and went to work. She woke up in the middle of the night with pain in her lower extremities, lower back, stomach, and at the injection site. She went to the local emergency room (ER) and reported her pain level as being an 8 on a scale of 10. The ER reported that there was no fever, blood pressure was normal, and there was no infection redness or swelling. The patient was TRENTAL and sent home. The office reported they would call the patient later to follow-up. Unspecified medical attention was sought. At the time of the report the patient's outcome was unknown. The patient did not report having a similar experience after her first dose of GARDASIL.  Additional information has been requested. Initial and follow-up information has been received from a nurse practitioner concerning an 17 year old white female with a minocycline hypersensitivity who on 22-AUG-2007 at 9:45 am was vaccinated into left antecubital with a first dose of GARDASIL (Lot #658222/0927U). Concomitant therapy included ADDERALL TABLETS, ORTHO TRI-CYCLEN LO, tetracycline, vitamins (unspecified) and hydrochloride. On 25-AUG-2007 the patient was in the office and reported that 2 days after vaccination (24-AUG-2007) she developed knee and leg pain bilaterally and swelling in the feet as bilateral arm pain with a rash on her lower legs. She went to her family doctor and was placed on MEDROL. On an unspecified date the patient recovered. On 04-SEP-2007 at 2:12 pm she was vaccinated with 0.5 ml second dose of GARDASIL. On 04-SEP-2007 immediately after vaccination she started to feel lightheaded. She reported not having eaten all day. She felt better and went to work. She woke up in the middle of the night with pain in her lower extremities, lower back, stomach, and at the injection site. She went to the local emergency room (ER) and reported her pain level as being an 8 on a scale of 10. The ER reported that there was no fever, blood pressure was normal, and there was no infection site redness or swelling. The patient was given TRENTAL and sent home. The office reported they would call the patient later to follow-up. Unspecified medical attention was sought. At the time of the report the patient's outcome was unknown. Additional information is not expected.
This is a spontaneous report received from a contactable consumer or other non-HCP, for a Pfizer sponsored program (159558). A patient (no qualifiers provided) received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had pain in extremity (soreness in the arm), with outcome of unknown. Additional information: Reporter wanted to find out where she can take her grandkids (12 years old, 13 years old and 25 years old) to get the Pfizer vaccine. Reporter said her neighbor did not have a major problem regarding the vaccine, only soreness in the arm. Follow-up attempts completed. No further information expected. Sender's comments: Linked report: US-PFIZER INC-202101190402 different patient, different event and same drug.
After confirmation x 2 of DOB, patient given adult vaccine dose. After vaccination it was noted that DOB different with patient still being 11 years old requiring pediatric vaccine.
It was about a seven hours after the shot, I sneeze and then my eyes swelled up and almost closed so that was swollen closed eyes, my throat as well.; It was about a seven hours after the shot, I sneeze and then my eyes swelled up and almost closed so that was swollen closed eyes, my throat as well.; I sneeze and then my eyes swelled up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient received BNT162b2 (BNT162B2), on 13Apr2022 as dose number unknown (booster), single (Lot number: FK9894) at the age of 66 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "High Blood pressure" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "hearing is not great" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for Covid-19 Immunization. The following information was reported: SNEEZING (non-serious) with onset Apr2022, outcome "unknown", described as "I sneeze and then my eyes swelled up"; EYE SWELLING (non-serious), PHARYNGEAL SWELLING (non-serious) all with onset Apr2022, outcome "not recovered" and all described as "It was about a seven hours after the shot, I sneeze and then my eyes swelled up and almost closed so that was swollen closed eyes, my throat as well.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of eye swelling, pharyngeal swelling, sneezing.  Additional information: Consumer stated, "The side effects was, it was about a seven hours after the shot, I sneeze and then my eyes swelled up and almost closed so that was swollen closed eyes.''When paraphrased the concern: Consumer stated, ''I am not understanding that. I can hear you but I am not understanding what you are saying? Could you verse that a little differently may be.''When again paraphrased the concern: Consumer stated, ''Yes that's correct and my throat as well. Reporter and Consumer stated, ''Seven hours.'' If still persisting or improved: Reporter stated, ''Still persists.'' Consumer stated, ''Yes the swelling has gone down but it's pretty swollen.'' Treatment:  Consumer stated, ''Yes I am, I took Benadryl.'' Laboratory tests: Consumer stated, ''I did have an Endoscopy and colonoscopy on Monday 11Apr (Year not clarified hence not captured in tab).'' Other Medications: Consumer stated, Yes  No follow-up attempts are possible. No further information is expected.
Left armpit swollen, hard and slight pain started 14 hours after shot.  After another 24 hours, hardness went away, just swollen.
Erythematous maculopapular rash limited to right side in trigeminal maxillary distribution with some discomfort in area, increasing amoutns (if I didn't know any better, I'd say this was a case of shingles)
Receiving outpatient rehab. for treatment of L shldr. pain, stiffness & weakness. Treatment consists of hot packs, electrical stimulation, therapeutic exercise and manual treatment to increase L shdr mobility.
07/30/08 8:00 pm patient started to experience some visions changes (blurry vision, seeing spots, decreased peripheral vision), at about 10:00 pm she had severe headache and numbness to bilateral hands and arms. Severe headache continued till about 2:00 am. Medicated with Tylenol 100 mg and Motrin.
About 6 hours after receiving the vaccine: Extreme chills, high fever (104F), night sweats, headache, severe bodyaches, period started unexpectedly I slept 32 hours (on and off) and then started to feel tightness in my chest and lightheadedness; swollen lymph node in left armpit
generalized sz-the witnessed duration was less than 10 mins-occured in mid afternoon; pt evaluated in ER & released;
Heart palpitations, heart rate of 166 bpm after light exercise. Shortness of breath, tremors. Resolved after 20+ minutes of rest.
A few minutes after receiving vaccine patient reported having a reaction, strange feeling in his tongue and throat, trouble breathing, and nausea.  Within 5 minutes of reporting patient felt better, and stated feeling 100% before leaving the pharmacy approximately 45 minutes after vaccination.  Refused treatment with benadryl, vitals done by EMT, refused hospital.
Swelling and itching at vaccine site, mostly in the evening time. Itching and rash at various part of her body, relieved by BENADRYL.
pfizer vaccine was in fridge beyond 30 days at time of administration. pharmacist did not know of this until after administration. discussed with pt. pt stated experienced fever, headache, nausea following vaccination. recommended repeating vaccination.
Bell's Palsy occurred 4 weeks after J&J vaccine.  Nonfunctioning left side of mouth   PREDNISONE 60 mg q d x 7 days
"Cried for 3-4 days. Nothing I could do would satisfy her" per mom.
Itchy Sensation - Near Injection Site; Rash - Near Injection Site; Swelling - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE RASH (Rash - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE RASH (Rash - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site). At the time of the report, PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE RASH (Rash - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the information provided, a strong temporal association and the established safety profile of mRNA-1273 vaccine, a causal association between the reported events and the product use cannot be excluded. The reported events are consistent with the known safety profile of the vaccine; Sender's Comments: Based on the information provided, a strong temporal association and the established safety profile of mRNA-1273 vaccine, a causal association between the reported events and the product use cannot be excluded. The reported events are consistent with the known safety profile of the vaccine
he experienced an unexplained symptom (unspecified); This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (he experienced an unexplained symptom (unspecified)) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In December 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced IMMUNISATION REACTION (he experienced an unexplained symptom (unspecified)). At the time of the report, IMMUNISATION REACTION (he experienced an unexplained symptom (unspecified)) outcome was unknown.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Reporter did not allow further contact
This is a spontaneous report from a contactable nurse. This report was received via a Pfizer sales representative. A female patient of an unspecified age (age: 82, unit: unspecified) and ethnicity received PREVNAR 13, intramuscular in the left deltoid on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced severe redness, swelling, fever, body aches on an unspecified date. The patient ended up in ER. Outcome of the events was unknown.
Temp of 100.1 and unproductive cough on 1/17; temp of 100.4 1/28;  O2 desaturation 88% on RA 1/28;  Diagnosed with Covid-19 on 1/18/2021 Patient passed away on 1/29/2021
On 10/4/21 a patient came in and requested to get the Covid Booster. They indicated that they had Pfizer and it had been more than 6 months since their 2nd dose. The patient did not have their immunization card with them. We did not give the previous doses so we attempted to verify the previous series on database and there was no record. We had the patient sign the attestation form and gave the Booster dose of Pfizer. Today on 10/7/21 the patient came back in with his card for us to add the Booster to it and we discovered he had Moderna not Pfizer. I called the patient later in the day to ask if he wanted us to call his primary care doctor and he said he had already contacted them.
Starting approximately 4 hours after injection: Extremely rapid heartbeat, 164 bpm, elevation over 100 bpm persisted approximately 4  hours   Lowered blood oxygen saturation, 88 percent, less than 90 percent persisted approximately 2 hours Light-headedness and shortness of breath, likely related to the above, persisted approximately 2 hours  Minor: Pain at injection site immediately and persisted 4 days.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), on 18Mar2021 at 09:00 as dose 1, single (Lot number: EN6206), in left arm and on 08Apr2021 at 12:00 as dose 2, single (Lot number: EP7533) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 23Dec2021 at 12:00 as dose 3 (booster), single (Lot number: 011F21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Sleep apnea" (unspecified if ongoing); "pre diabeted throid issues" (unspecified if ongoing); "afib" (unspecified if ongoing). Concomitant medication(s) included: UNITHROID, start date: 01Oct2021, stop date: 30Jul2022; METFORMIN, start date: 17Sep2020, stop date: 30Jul2022. The following information was reported: VACCINATION FAILURE (medically significant) with onset Apr2022, outcome "unknown", COVID-19 (medically significant) with onset Apr2022, outcome "recovered" (2022) and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2022) negative, notes: tested negative for 2 days; (Apr2022) positive; (Apr2022) negative, notes: Tested negative 4th day in; (Apr2022) negative, notes: tested negative 5th day; (Apr2022) negative, notes: tested negative 6th day; (Apr2022) negative, notes: tested negative 7th day; (Apr2022) negative, notes: tested negative 8th day; (Apr2022) positive, notes: tested positive 9th day; (Apr2022) positive, notes: tested positive 10th day; (Apr2022) positive, notes: tested positive 10th day thru 14th day; (Apr2022) positive, notes: tested positive 10th day thru 14th day; (Apr2022) positive, notes: tested positive 10th day thru 14th day; (Apr2022) positive, notes: tested positive 10th day thru 14th day; (Apr2022) negative, notes: then negative no symptoms the whole time. Therapeutic measures were taken as a result of covid-19.  Clinical information: Patient had no known allergies. Patient stated he was exposed and tested negative for 2 days then positive and went right on paxlovid for 5 days.  No follow-up attempts are needed. No further information is expected.
Bell's palsy. Facial paralysis in the morning of March 19th 2021, 8 days after the first dosis of Moderna Covid vaccine
Fussy, decreased appetite, some vomiting, poor sleep in the week following immunization. As of 9/15/03, parents do not believe the child has returned to previous status or temperament. Exam and development normal on 9/15/03.
This is a spontaneous report from a contactable physician via a Company representative. A 17 year-old female patient of an unspecified race and ethnicity received a single dose of TRUMENBA via an unspecified route of administration an unspecified date for immunization. The patient medical history and concomitant medications were not reported. The patient experienced generalized malaise on 03Jun2017. Outcome was unknown. No follow-up attempts are possible. No further information is expected.
Pt arrived to ED via EMS from home for seizure like activity and resulted AMS. Per EMS, on arrival to scene Pt was noted to be soiled, and A&Ox1. Per EMS, family stated that Pt was acting different after the seizure like activity and what appeared to be post ictal period. Pt has no history of seizure, but has a h/o brain aneurysm with clips. CT head revealed 7 mm hyperdense mass lesion within the right frontal lobe. Further diagnostic evaluation with LP/opening pressures is requested by neurosurgery. Incidental COVID finding tested in ED for Trauma with possible surgery.
Patient developed Pityriasis rosea two days after her booster immunization. She also had swollen lymph nodes in her armpit.
Severe stomach pain; Nausea; Vomited, multiple times; Unable to sleep, uncomfortable; Unable to sleep, uncomfortable; Weak; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received first dose bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 20Apr2021 14:30 (Batch/Lot Number: EW0158; Expiration Date: Jul2021, NDC number: 59267-1000-02) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were none.  Patient stated she had severe symptoms and side effects and she did not know what to do. Patient stated she had her first shot yesterday at 2:30 in the afternoon. Patient stated she went home and then went to bed at midnight. Patient stated she had severe stomach pain, throughout her stomach, and by 21Apr2021 1 am, she had nausea, and vomited multiple times. Patient stated she had the stomach pain, nausea and vomiting throughout the night. Patient stated, she tried calling Pfizer last night but it was closed. Patient stated she got the number from the vaccine paper, and it also had information about the V-Safe health checker, but it did not give the time that Pfizer was open. Patient stated, she didn't know who to call or what to do. Patient stated she was still in pain and she was not sure if she needs to go to the emergency room. Patient stated she tried to call an emergency room near her house, and they could not evaluate her over the phone, and told her to come to the hospital. Patient stated she did not have health insurance right now.   Reclarified, she didn't go to the emergency room because she was afraid of the hospital bill, as she didn't have health insurance right now. Reclarified, Patient asks for recommendations as to what she should do about the stomach pain. Patient agrees to continue with a safety report.  Patient stated she did not have a healthcare provider. As for Stomach pain, onset time was midnight or 1 am, outcome was it was improved, it calmed down than, from when it started, but she still feels it in her entire stomach. As for Nausea, onset time was 1 am. As for Vomited, onset time was 1 am. Patient reported that she also was unable to sleep, as she was uncomfortable, and she was weak. As for Unable to sleep, uncomfortable, onset time was 1 am, outcome was patient answers as she hasn't been able to sleep, it has remained the same. As for Weak, onset time was 1 am, outcome was patient answers as it has remained the same. As for facility patient stated a vaccination site was created at the. No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional Vaccines Administered on Same Date of the Pfizer Suspect. No AE required a visit to emergency Room and Physician Office. No Prior Vaccinations (within 4 weeks) and no AE following prior vaccinations. No family Medical History Relevant to AEs. No Relevant Tests. The outcome of the event Severe stomach pain was recovering, of event Vomited, multiple times and Nausea was recovered on 21Apr2021, of other events was not recovered.
Returned to clinic on 07/05/02 with left thigh swelling.10x8cm induration and erythema left thigh =29cm, right thigh=26cm. Pt examined by FNP. Ibuprophen and moist heat recommended and told to call for fever > 100.5.
I had known side effects beginning 6 hours after injection and lasting until about 36 hours after injection including fatigue, nausea, chills, low fever, and muscle soreness. 4 days after injection I began experiencing shortness of breath and dizziness similar to when I had COVID-19 in March and April of 2020.
TICKING SOUND IN THE BACK OF NECKTICKING SOUND IN SKULL; ANNOYANCE; This spontaneous report received from a patient concerned a 59 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcohol user, non-smoker, coronary artery disease, high blood pressure, anxiety, and depression, and other pre-existing medical conditions included the patient have no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986 expiry: UNKNOWN) dose was not reported, administered on 12-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAY-2021, the subject experienced ticking sound in the back of neck. On 12-MAY-2021, the subject experienced ticking sound in skull. On 12-MAY-2021, the subject experienced annoyance. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from ticking sound in the back of neck, ticking sound in skull, and annoyance. This report was non-serious.
11 month old pt received FLUMIST when should have received injectiable flu. 2 days after administered developed a fever and diarrhea. Fever actually occurred several day received MIST.
Day of vaccine: No symptoms. Next day: Slightly achy, occasional mild nausea, occasional mild light-headedness. Day 2: Headache, muscle aches, bone aches, more prevalent nausea. Feel "feverish", though no elevated temperature present.